Response to: "MuSK-positive myasthenia may be triggered not only by SARS-CoV-2".

We thank Drs Finsterer and Scorza for their comments on our case report "Myasthenia gravis associated with anti-MuSK antibodies developed after SARS-CoV-2 infection". At least 6 patients with new-onset myasthenia gravis (MG) after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have been published so far. In these reports, the latency between the first signs of Coronavirus Disease 2019 (COVID-19) and symptoms of MG ranged from 5 to 30 days.